Form 4 Tracker
Marshall Fordyce

Director, PRESIDENT AND CEO · 11 filings · Latest: Sep 15, 2026

Vera Therapeutics, Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
VERA
MARSHALL FORDYCE—Feb 26, 2025
Proposed Sale
$27.109,075$245.9K—
VERA
MARSHALL FORDYCE—Jan 8, 2025
Proposed Sale
$42.1017,500$736.8K—
VERA
MARSHALL FORDYCE—Dec 18, 2024
Proposed Sale
$43.9117,500$768.4K—
VERA
MARSHALL FORDYCE—Dec 11, 2024
Proposed Sale
$46.9217,500$821.1K—
VERA
MARSHALL FORDYCE—Nov 25, 2024
Proposed Sale
$48.3119,375$936.0K—
VERA
MARSHALL FORDYCE—Nov 13, 2024
Proposed Sale
$48.5430,625$1.5M—
VERA
MARSHALL FORDYCE—Oct 23, 2024
Proposed Sale
$40.7119,375$788.8K—
VERA
MARSHALL FORDYCE—Oct 9, 2024
Proposed Sale
$38.6415,625$603.8K—
VERA
MARSHALL FORDYCE—Sep 25, 2024
Proposed Sale
$46.717,500$350.3K—
VERA
MARSHALL FORDYCE—Sep 11, 2024
Proposed Sale
$37.5531,250$1.2M—
VERA
MARSHALL FORDYCE—Aug 28, 2024
Proposed Sale
$37.6530,320$1.1M—

← Previous

Page 2 of 2